Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.
about
Roxadustat in the treatment of anaemia in chronic kidney disease.2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2.Roles of 2-oxoglutarate oxygenases and isopenicillin N synthase in β-lactam biosynthesisReactive Oxygen Species Formation in the Brain at Different Oxygen Levels: The Role of Hypoxia Inducible FactorsHIF-1, Metabolism, and Diabetes in the Embryonic and Adult Heart
P2860
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Molecular and cellular mechani ...... inhibitors in clinical trials.
@en
Molecular and cellular mechani ...... inhibitors in clinical trials.
@nl
type
label
Molecular and cellular mechani ...... inhibitors in clinical trials.
@en
Molecular and cellular mechani ...... inhibitors in clinical trials.
@nl
prefLabel
Molecular and cellular mechani ...... inhibitors in clinical trials.
@en
Molecular and cellular mechani ...... inhibitors in clinical trials.
@nl
P2093
P2860
P50
P356
P1433
P1476
Molecular and cellular mechani ...... inhibitors in clinical trials.
@en
P2093
Anthony Tumber
Dong Zhang
Helen Morcrette
James P Holt-Martyn
Kerstin Lippl
Thomas M Leissing
Timothy D W Claridge
P2860
P304
P356
10.1039/C7SC02103H
P50
P577
2017-09-11T00:00:00Z